amodiaquine has been researched along with Nervous System Disorders in 2 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, K | 1 |
| Matsumoto, K | 1 |
| Kurauchi, Y | 1 |
| Hisatsune, A | 1 |
| Seki, T | 1 |
| Katsuki, H | 1 |
| Adonis-Koffy, L | 1 |
| Daubrey, T | 1 |
| Kouadio, A | 1 |
| Timité-Konan, AM | 1 |
| Kabran, J | 1 |
2 other studies available for amodiaquine and Nervous System Disorders
| Article | Year |
|---|---|
A Nurr1 agonist amodiaquine attenuates inflammatory events and neurological deficits in a mouse model of intracerebral hemorrhage.
Topics: Amodiaquine; Animals; Cerebral Hemorrhage; Disease Models, Animal; Inflammation Mediators; Macrophag | 2019 |
[Misunderstood neurological side effects of amodiaquine: apropos of 35 cases in children at Central University Hospital of Yopougon at Abidjan, Côte d' Ivoire].
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Re | 2003 |